Caevisus is a technology company.
Caevisus has raised $20K across 1 funding round.
Caevisus has raised $20K in total across 1 funding round.
Caevisus has raised $20K in total across 1 funding round.
Caevisus's investors include Elevate Ventures.
Caevisus is an early-stage Fort Wayne, Indiana-based startup developing wearable medical devices for orthopedic analysis, specifically targeting soft tissue assessment at the knee during movement. The company owns a key patent enabling licensees to build wearables that combine infrared time-of-flight sensors with inertial measurement units (IMUs) for precise motion and tissue dynamics capture[3][2]. It serves orthopedic clinicians, athletes, and patients needing non-invasive knee diagnostics, solving the problem of real-time, dynamic soft tissue evaluation without invasive imaging like MRI, which is static and costly. Caevisus is actively raising funds to advance its prototype, signaling early growth momentum in the medtech wearable space[2].
Caevisus emerged from Fort Wayne's startup ecosystem as a hardware-focused medtech venture, though specific founding year, founders, or their backgrounds are not detailed in available sources. The core idea stems from its patented technology, which integrates infrared time-of-flight (for depth-sensing tissue analysis) with IMUs (for motion tracking), addressing gaps in wearable orthopedics[3]. Early traction includes pitching at investor events and a current funding round for device development, positioning it among peers like other wearable medtech firms in pitch showcases[2][4].
Caevisus rides the wave of AI-enhanced wearables and precision medtech, aligning with trends in computer-aided diagnostics seen in Olympus's OLYSENSE platform for GI endoscopy, which boosts polyp detection by up to 230% via AI[1]. Timing is ideal amid rising demand for remote, motion-based orthopedics post-COVID, fueled by aging populations and sports injuries; market forces like falling sensor costs and FDA interest in wearables favor it. By enabling licensees, Caevisus influences the ecosystem like component providers in AI hardware, potentially expanding to veterinary or human orthopedics akin to Qentoros[3][4].
Caevisus's funding push could unlock prototypes and partnerships, with next steps likely including clinical pilots and licensee deals to validate knee analytics. Trends like sensor miniaturization and AI integration (e.g., time-of-flight with ML for predictive injury models) will shape its path, evolving its influence from niche IP holder to enabler in a $50B+ wearables market. As a Fort Wayne medtech player, success hinges on trials proving efficacy over competitors, tying back to its promise of transforming knee care from reactive to proactive[2][3].
Caevisus has raised $20K across 1 funding round. Most recently, it raised $20K Seed in July 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2022 | $20K Seed | Elevate Ventures |